| Literature DB >> 35110309 |
Tessy Boedt1,2, Nele Willaert3, Sharon Lie Fong4,5, Eline Dancet4,5, Carl Spiessens4,5, Filip Raes2,3, Christophe Matthys6,7, Katleen Van der Gucht2,3.
Abstract
INTRODUCTION: Infertility and its treatment bring a considerable emotional burden. Increasing evidence demonstrates the effectiveness of smartphone-delivered mindfulness apps for reducing symptoms of emotional distress in both clinical and non-clinical populations. Evidence on this topic in women, men and couples experiencing infertility is currently under-represented. The aim of the MoMiFer study is, therefore, to investigate the efficacy of a stand-alone mobile mindfulness app on symptoms of emotional distress and fertility-related quality of life in people experiencing infertility. METHODS AND ANALYSIS: This study is an exploratory randomised controlled trial (RCT) with open enrollment. The primary outcomes are symptoms of emotional distress and fertility-related quality of life. Secondary outcomes are mindfulness skills, repetitive negative thinking, self-compassion, user-rated quality of the stand-alone mobile mindfulness app and use of the app. Experience sampling method and standardised self-report questionnaires are combined within a repeated measures design to measure the effects of the stand-alone mobile mindfulness app on the primary and secondary outcomes, apart from the use of the app. The latter will be evaluated through app tracking. People, including women, men and couples, experiencing infertility (n=60) will be randomised to an intervention group receiving the stand-alone mobile mindfulness app for 3 months or a wait-list control group. The app follows the format and content of Mindfulness-Based Stress Reduction. Data will be collected at baseline, at 1.5 months and 3 months after randomisation. Analysis will be according to intention to treat and based on general linear modelling and multilevel mixed-effects modelling. ETHICS AND DISSEMINATION: This study received approval from the Medical Ethical Committee of the Leuven University Hospital (Belgium). The findings of this exploratory RCT will be disseminated through presentations at public lectures, scientific institutions and meetings, and through peer-reviewed scientific articles. TRIAL REGISTRATION NUMBER: NCT04143828. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: mental health; public health; subfertility
Mesh:
Year: 2022 PMID: 35110309 PMCID: PMC8811542 DOI: 10.1136/bmjopen-2021-050088
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Overview of the MoMiFer-RCT. ESM, experience sampling method; QOL, quality of life; RCT, randomised controlled trial.
Outcomes, method(s) of assessment and timing of assessment
| Outcomes | Method(s) of assessment | Timing of assessment | ||
| Primary outcome measures | Baseline | 1.5 months | 3 months | |
| Fertility-related quality of life | Self-report Q | X | X | X |
| Symptoms of emotional distress | ESM | X | X | X |
| Secondary outcome measures | ||||
| Mindfulness skills | Self-report Q | X | X | X |
| Repetitive negative thoughts | Self-report Q | X | X | X |
| Self-compassion | Self-report Q | X | X | X |
| User-rated quality of the app | Self-report Q | X | ||
| Use of the app | App tracking | X | X | |
| Background information | Self-report Q | X | ||
ESM, experience sampling method; Q, questionnaire.